<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2565-005X</journal-id>
<journal-title><![CDATA[Gaceta mexicana de oncología]]></journal-title>
<abbrev-journal-title><![CDATA[Gac. mex. oncol.]]></abbrev-journal-title>
<issn>2565-005X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oncología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2565-005X2023000500138</article-id>
<article-id pub-id-type="doi">10.24875/j.gamo.23000014</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Síndrome Doege-Potter secundario a tumor fibroso solitario pulmonar. A propósito de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Doege-Potter syndrome secondary to a pulmonary solitary fibrous tumor. A purpose of a case]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz-Lerma]]></surname>
<given-names><![CDATA[Amelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Doello-González]]></surname>
<given-names><![CDATA[Kevin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ríos-Pelegrina]]></surname>
<given-names><![CDATA[Rosa Ma.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgado-Pérez]]></surname>
<given-names><![CDATA[Juan R.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Virgen de las Nieves Servicio de Oncología Médica ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto de Investigación Biosanitaria de Granada Instituto de Investigación Biosanitaria de Granada ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital San Cecilio Servicio de Anatomía Patológica ]]></institution>
<addr-line><![CDATA[Granada ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>22</volume>
<fpage>138</fpage>
<lpage>142</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2565-005X2023000500138&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2565-005X2023000500138&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2565-005X2023000500138&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El tumor fibroso solitario es una neoplasia poco frecuente. La asociación de hipoglucemia como manifestación paraneoplásica se conoce como síndrome de Doege-Potter. Es una entidad clínica muy poco frecuente y de difícil diagnóstico. Se trata de un síndrome paraneoplásico causado por la activación por IGF-2 del receptor de insulina. El objetivo del presente artículo es exponer un caso de síndrome de Doege-Potter en una paciente de 75 años. Además, hemos realizado una búsqueda bibliográfica para contrastar con otros casos similares.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The solitary fibrous tumor is a rare neoplasm. The association of hypoglycemia as a paraneoplastic manifestation is known as Doege-Potter Syndrome. It is a very rare clinical entity and difficult to diagnose. It is a paraneoplastic syndrome caused by IGF-2 activation of the insulin receptor. The objective of this article is to expose a case of Doege-Potter Syndrome in a 75-year-old patient. In addition, we have carried out a bibliographic search to contrast with other similar cases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Tumor fibroso solitario]]></kwd>
<kwd lng="es"><![CDATA[Síndrome de Doege-Potter]]></kwd>
<kwd lng="es"><![CDATA[Hipoglucemia]]></kwd>
<kwd lng="en"><![CDATA[Solitary fibrous tumor]]></kwd>
<kwd lng="en"><![CDATA[Doege-Potter syndrome]]></kwd>
<kwd lng="en"><![CDATA[Hypoglucemia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos-Seoane]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Madera-Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Canto-Argiz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Doege-Potter syndrome:What hypoglycemia hid]]></article-title>
<source><![CDATA[Rev Clin Esp (Barc)]]></source>
<year>2019</year>
<volume>219</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>346-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crowley]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Lonergan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[O'Callaghan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Joyce]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Morita]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Conlon]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IGF-2 mediated hypoglycemia and the paradox of an apparently benign lesion:a case report &amp;review of the literature]]></article-title>
<source><![CDATA[BMC Endocr Disord]]></source>
<year>2022</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>262</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flores Cruz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aguila Gómez]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo Vargas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alarcón Delgado]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Doege-Potter, tumor fibroso solitario endotorácico hipoglicemiante, ¿cuándo y cómo lo diagnóstico?Y ¿cual es mi conducta final?:presentación de un caso y revisión de la literatura]]></article-title>
<source><![CDATA[Rev Med La Paz]]></source>
<year>2019</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-57</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sandoval-Alzate]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Parra-Gamboa]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Angulo-Casalis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Doege Potter. Presentación de casos]]></article-title>
<source><![CDATA[Acta Médica Colombiana]]></source>
<year>2020</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalebi]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Hale]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour:case report and update on the Doege-Potter syndrome]]></article-title>
<source><![CDATA[J Cardiothorac Surg]]></source>
<year>2009</year>
<volume>4</volume>
<page-range>45</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
